- Net revenue of $821 million for fiscal year 2025, with a constant currency revenue of $834 million.
- International cannabis revenue surged by 71% in Q4 and 19% for the fiscal year.
- Adjusted EBITDA expected to range between $62 million and $72 million for fiscal year 2026.
Tilray Brands, Inc. (NASDAQ:TLRY) is a prominent player in the cannabis industry, known for its diverse portfolio that spans cannabis, beverages, and wellness products. The company reported a net revenue of $821 million for fiscal year 2025, with a constant currency revenue of $834 million. Despite a $13 million revenue impact from strategic initiatives and SKU rationalization in the fourth quarter, Tilray achieved its second-highest consolidated adjusted EBITDA in history during the period.Tilray's international cannabis revenue surged by 71% in Q4 and 19% for the fiscal year, with European cannabis revenue increasing by 112% when excluding Australia.
The company expanded its beer presence in the U.S. by acquiring four craft brands from Molson Coors and launched Project 420 to integrate its craft beer businesses. Additionally, Tilray introduced hemp-derived Delta-9 THC drinks in the U.S., reaching 1,300 distribution points across 13 states.The beverage segment experienced a 19% revenue growth, reaching $241 million, while the wellness segment grew by 9% to $60 million.
Tilray maintains a strong balance sheet with $256 million in cash and marketable securities, having repaid approximately $100 million in total debt. The company is leveraging AI to enhance efficiency and growth, particularly in its global greenhouse operations.Despite a net loss of $30.9 million, or -$0.038 per share on an adjusted basis, in the fourth quarter, primarily due to operational challenges and strategic adjustments, Tilray remains optimistic about future growth. For fiscal year 2026, the company expects adjusted EBITDA to range between $62 million and $72 million, with a focus on expanding its global supply chain and cultivation footprint.